VIRIDIAN THERAPEUTICS

Serial Number 90556929
Registration 7021544
700

Registration Progress

Application Filed
Mar 3, 2021
Under Examination
Approved for Publication
Jan 24, 2023
Published for Opposition
Jan 24, 2023
Registered
Apr 11, 2023

Trademark Image

VIRIDIAN THERAPEUTICS

Basic Information

Serial Number
90556929
Registration Number
7021544
Filing Date
March 3, 2021
Registration Date
April 11, 2023
Published for Opposition
January 24, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Apr 11, 2023
Registration
Registered
Classes
042

Rights Holder

Viridian Therapeutics, Inc.

03
Address
221 Crescent St
Waltham, MA 02453

Ownership History

Viridian Therapeutics, Inc.

Original Applicant
03
Boulder, CO

Viridian Therapeutics, Inc.

Owner at Publication
03
Boulder, CO

Viridian Therapeutics, Inc.

Original Registrant
03
Waltham, MA

Legal Representation

Attorney
Valerie Brennan

USPTO Deadlines

Next Deadline
1259 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-04-11)
Due Date
April 11, 2029
Grace Period Ends
October 11, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

34 events
Date Code Type Description Documents
Oct 20, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Oct 20, 2025 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Oct 20, 2025 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
May 8, 2024 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
May 8, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
May 8, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
May 8, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Apr 11, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Apr 11, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jan 24, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 24, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 4, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 18, 2022 EXPT T EXPARTE APPEAL TERMINATED Loading...
Dec 18, 2022 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 15, 2022 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Dec 15, 2022 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Dec 15, 2022 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Dec 15, 2022 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Nov 10, 2022 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED Loading...
Nov 10, 2022 EXPI T EX PARTE APPEAL-INSTITUTED Loading...
Nov 10, 2022 JURT T JURISDICTION RESTORED TO EXAMINING ATTORNEY Loading...
Nov 10, 2022 EXAF T EXPARTE APPEAL RECEIVED AT TTAB Loading...
May 10, 2022 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
May 10, 2022 GNFR O FINAL REFUSAL E-MAILED Loading...
May 10, 2022 CNFR R FINAL REFUSAL WRITTEN Loading...
Mar 30, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 28, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 28, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Sep 26, 2021 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Sep 26, 2021 GNRT F NON-FINAL ACTION E-MAILED Loading...
Sep 26, 2021 CNRT R NON-FINAL ACTION WRITTEN Loading...
Sep 25, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 2, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 6, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Scientific research and development services in the field of biotechnology in the nature of immunotherapeutic treatments for autoimmune diseases and immunological disorders
First Use Anywhere: Jan 19, 2021
First Use in Commerce: Jan 19, 2021

Classification

International Classes
042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THERAPEUTICS"